Table 1. Diagnostic criteria for atopic dermatitis*
|
|
- Kerry Ward
- 6 years ago
- Views:
Transcription
1 Pediatric Atopic Dermatitis: Utilizing OMT as an Adjunct Treatment Alexa R. Leone, DO,* Michael P. Rowane, DO, MS, FAAFP, FAAO,** Jenifer R. Lloyd, DO*** *Traditional Intern, University Hospitals Richmond Medical Center, Cleveland, OH **Associate Clinical Professor of Family Medicine and Psychiatry, Case Western Reserve University; Director of Medical Education, University Hospitals Regional Hospitals; Director of Osteopathic Medical Education, University Hospitals Cleveland Medical Center, Cleveland, OH ***Director, Dermatology Residency Program, University Hospitals Regional Hospitals; Department of Dermatology, Case Western Reserve University, Cleveland, OH Disclosures: None Correspondence: Michael P Rowane, DO; micheal.rowane@uhhospitals.org Abstract Atopic dermatitis is a common, chronic, inflammatory skin condition that can affect people of any age. The etiology of atopic dermatitis is multi-factorial, with genetics, environment, and impaired immune response as predominant factors. Because atopic dermatitis is an inflammatory process that results in somatic dysfunction, the dermatologist can use osteopathic manipulative techniques as adjunct tools in pediatric atopic dermatitis management. Here we describe osteopathic manipulative treatments that may aid in the management of pediatric atopic dermatitis. Introduction Atopic dermatitis (AD) is a chronic and relapsing, pruritic, inflammatory disease occurring most frequently in children, though it also affects adults. 1 Atopic dermatitis is often associated with a personal or family history of allergies, rhinitis, and asthma. In the past 30 years, the prevalence of AD has almost tripled in developed countries. In the United States, the highest prevalence occurs on the east coast and in Utah, Idaho, and Nevada. African American race and an education level beyond high school are significantly associated with a higher prevalence of eczema. 1,2 Approximately 15 percent to 30 percent of children and 2 percent to 10 percent of adults are affected. 1-3 Early onset is common, with up to 60 percent of patients affected during the first year of life, and 90 percent affected by age 5. 3 Less than 10 percent of AD patients first develop symptoms as an adult. 1,3 Seventy percent to 90 percent of children have resolution of the disease by adulthood. It is important to recognize that AD may have a significant impact on the morbidity and quality of life in the pediatric population. Continual scratching at night can lead to an average of 1.9 hours of lost sleep per night for the patient, and 2.1 hours of lost sleep per night for the family. 4 Patients with a visible skin disorder may suffer socially, and the need for frequent doctor visits and applications of topical medications may interfere with daily life. Central obesity and ADHD have been loosely associated with atopic dermatitis, as have daytime tiredness, dependence, irritability, and fearfulness. 3,4 The severity of atopic dermatitis has been correlated with depression, stress, and anxiety, which may have a negative effect on the immune system due to increases in cortisol levels. 5 Like any chronic disease, the financial burdens of management are immense. One study concluded that the personal financial cost of managing atopic dermatitis was greater than that of managing asthma. 4 The same study found that families of children with moderate or severe AD had significantly higher family scores than families of diabetic children. By looking at AD through an osteopathic lens, dermatologists can recognize the impact of atopic dermatitis on a patient s overall wellbeing. Osteopathic manipulative treatment (OMT) is a non-invasive, manual form of treatment by which physicians can apply osteopathic principles and practices to atopic dermatitis. Here, we look at atopic dermatitis in the pediatric population as a source of somatic dysfunction, affecting not only the visible skin but also the immune system, surrounding fascia, lymphatic system, and patients mental and emotional wellbeing. We review and discuss OMT techniques that can serve as adjunct treatments for atopic dermatitis, recognizing that further research is needed to study their effectiveness and value. Background and Presentation The term atopic dermatitis and eczema are often used interchangeably and can be thought of as the same diagnosis. However, eczema is more strictly defined as a reaction pattern of the skin, which in children is most commonly caused by atopic dermatitis. 1 Other causes of an eczematous pattern of reaction include irritant contact dermatitis, allergic contact dermatitis, dyshidrotic eczema, asteatotic eczema, and lichen simplex chronicus. 1,2 The diagnosis of AD is made clinically and is based on the distribution of lesions, morphology, histologic findings, and associated clinical signs. 1,3 A complete history and physical is needed to aid in diagnosis and treatment. The most widely used and accepted diagnostic criteria, created in 1980 by Hanifin and Raijka, were revised in 2003 by the American Academy of Dermatology to include an approach to AD that is suitable for diagnosis in infants, children, and adults (Table 1). 1,3 Depending on the patient Table 1. Diagnostic criteria for atopic dermatitis* Essential Features (must be present) Important Features (usually present) Associated Features (nonspecific; suggests diagnosis) Exclusionary Conditions age and presentation, it may be necessary to conduct further testing, such as serum immunoglobulin E, patch testing, fungal testing, and genetic testing, to rule out other common conditions. Pathogenesis Although much is known about the immunology behind atopic dermatitis, there is no reliable biomarker for diagnosis of the disease. It is known that serum levels of immunoglobulin E (IgE) may be elevated in patients with AD; however, about 20 percent of patients have normal serum IgE levels and no allergen reactivity. 1-3,6 Elevated IgE levels are non-specific and can be found in 55 percent of the general population. IgE levels have not been found to be correlated with activity levels of the disease, and therefore can only be considered supporting evidence for the diagnosis. 1,3,6 Increased blood eosinophils and tissue mast cells have also been studied, but are neither sensitive nor specific for AD. 4,6,7 Several factors suggest that AD patients have reduced T-cell-mediated immunity. Many T-lymphocyte subsets, cytokines and chemokines are altered in AD, including CD-30 serum levels, macrophage-derived chemoattractant, interleukins-12, -16, -18, and -31, and thymus and 1. Pruritus 2. Eczema (acute, subacute, or chronic) a. Chronic or relapsing history b. Typical morphology and age-specific patterns - Facial, neck, and extensor involvement in infants and children - Current or previous flexor lesions - Sparing of the groin and axillary regions 1. Early age of onset 2. Atopy a. Personal and/or family history b. Raised IgE levels 3. Xerosis 1. Atypical vascular responses: a. Facial pallor b. White dermatographism 2. Keratosis pilaris, pityriasis alba, hyperlinear palms, ichthyosis 3. Ocular/periorbital changes 4. Perioral/periauricular lesions 5. Perifollicular accentuation, lichenification, prurigo lesions A diagnosis of AD depends on exclusion of: scabies, seborrheic dermatitis, contact dermatitis (irritant or allergic), ichthyosis, cutaneous T-cell lymphoma, psoriasis, photosensitivity dermatoses, immune-deficiency diseases, and erythroderma of other causes. *Adapted from: Eichenfield LF, Hanifin JF, Luger TA, Stevens SR, Pride HB. Consensus conference on pediatric atopic dermatitis. J Am Acad Dermatol Dec;49(6):
2 activation-regulated chemokine. 3,6 However, none have been found reliable for clinical use in diagnosis or monitoring progression of disease. Other clinical evidence indicates alteration in immune function. Children with atopic dermatitis may develop severe, diffuse cutaneous infection with herpes simplex virus whether or not their dermatitis is active. 1 It has also been shown that the incidence of contact allergy may be lower than normal in AD patients, increasing risks associated with poison ivy and other common contact irritants. Patch testing is generally positive for numerous aeroallergens in children with AD, including house dust, mites, cockroaches, mold mix, and grass mix. 1,3,6 In addition to the specific immunologic factors that play a role in the pathogenesis of AD, recent research has been focusing on the loss of the skin s barrier function, which results in generalized xerosis and pruritus. Abnormally dry skin and a much lower threshold for itching are hallmark traits of eczema. AD starts with itching and progresses to a rash, which often itches more, and continual scratching only makes the rash worse. This is classically known as the itch-scratch cycle. 1-4,6 There are two risk factors for AD: 1) family history of atopy, and 2) mutations of the FLG gene. 6 About 70 percent of children with AD have a positive family history of the disease. 8 The FLG gene encodes profilaggrin, which is degraded into filaggrin monomers, proteins that play an important role in differentiation and formation of the epidermal stratum corneum. 6 The loss of the barrier function of the stratum corneum contributes to the predisposition of AD patients to have chronically dry, itchy skin. This propagates the itch-scratch cycle. Most patients with AD, unless they are too young to understand, try to control their scratching; it occurs mostly at night, when conscious effort dissipates. Acute inflammation of the skin begins with erythematous papules, which progress to excoriations, erosions, and serous exudate. 1 Subacute dermatitis is associated with excoriated and irritated papules. Chronic dermatitis results in lichenification of the skin and fibrotic papules, often seen over the popliteal fossa in children with AD. All three types of reaction can simultaneously co-exist in the same individual. 1,2 On a lichenified plaque, normal skin lines may become accentuated, resembling a washboard appearance. 1 Management Management of atopic dermatitis in the pediatric population can be a challenge. AD is characterized by periods of flares, or acute worsening, alternating with periods of remission following treatment. 6 Treatment goals are to eliminate inflammation and infection, preserve and restore the stratum corneum using barrier emollients, limit pruritus to prevent damage to the skin, and control other exacerbating factors of the disease. 1-3,6 Symptom management for atopic dermatitis is of upmost importance. These measures start with good skin-care practices and preventing dry skin. Topical emollients are a mainstay of therapy and should be applied liberally after bathing. 8 Moisturizers work to address the negative effects of epidermal barrier dysfunction. 6,8 Children should bathe in warm rather than hot water, and use mild, unscented soaps. 8 Lubricating ointments, which are often greasy and impractical for daytime use, should be used at night for their superior hydrating properties. In some pediatric patients, emollients may be adequate to deal with existing lesions, and anti-inflammatory therapies can be saved for new lesions. In others, both new and previously involved lesions may benefit from application of topical corticosteroids (TCSs) or topical calcineurin inhibitors (TCIs) on a scheduled and intermittent basis. 6 TCSs (1x - 2x per week) and TCIs (2x - 3x per week) can be used in conjunction with moisturizers, 6 though TCIs should only be used in children over 2 years of age. 1,6,8 Only low-potency (class 6 or 7) steroids should be used on the face, axillae and groin in order to minimize side effects such as acne, striae, telangiectasia, and atrophy. 8 Ointments, which are more potent than creams, should be avoided on open or oozing lesions and intertriginous folds. Proactive use of TCSs and TCIs is an effective strategy for AD flares, but there are no studies that compare the two classes of topical therapy. 6 The optimal interval of scheduled intermittent use is not clear due to variations between studies. Current treatment guidelines do not recommend more than twice-daily application of topical corticosteroids. 6,8 TCIs should not be used on open lesions, as they cause skin burning and irritation. Patients should also be counseled on using proper sun protection. The U.S. Food and Drug Administration (FDA) recommends avoiding longterm use of TCIs in all patients. 8 The use of sedating antihistamines in children has been shown beneficial in treating pruritus and sleep disturbance associated with AD. 1,8 Antibiotics should be reserved for the treatment of acutely infected lesions associated with atopic dermatitis. 6,8 Environmental modifications are recommended and well studied. Patients with atopic dermatitis should avoid known irritants, such as wool, acids, bleaches, and solvents. 1,6,8 Any chemical or environmental triggers that are known and specific to the individual should be avoided. Smooth clothing and avoidance of irritating, manufactured fabrics may help minimize eczema flares. There are no studies to date showing that specialized clothing (such as silverimpregnated garments) is warranted. 6 Two new and emergent treatments for atopic dermatitis include crisaborole, a topical boronbased phosphodiesterase-4 inhibitor (PDE-4), and dupilumab, an antibody that inhibits interluekin-4/ IL-13 receptor α chain. 18 The FDA approved dupilumab to treat adults with moderate to severe atopic dermatitis. In three placebo-controlled clinical trials with a total of 2,119 adult participants, all with moderate to severe atopic dermatitis inadequately controlled on topical medication(s), dupilumab was established as safe and efficacious. In all trials, dupilumab significantly improved measures of skinclearing intensity and severity of disease at 16 weeks compared to placebo. Dupilumab is administered via subcutaneous injection every other week after an initial loading dose. 18 In contrast to dupilumab, Table 2. Osteopathic manipulative treatment techniques used in atopic dermatitis 5,11 OMT Technique Type Mechanism of Action Contraindications Myofascial Release Soft-tissue Technique Lymphatic Technique passive or active passive passive which can only be used in adults, the FDA approved crisaborole ointment 2% for the treatment of mild to moderate atopic dermatitis in patients 2 years of age and older. The safety and efficacy of crisaborole topical were established in two placebo-controlled trials with 1,522 participants, ranging from 2 years to 79 years of age, with mild to moderate atopic dermatitis. Participants applied crisaborole ointment twice a day for 28 days. Crisaborole-treated patients achieved higher Investigator s Statistic Global Assessment (ISGA) scores than vehicle-treated patients. 18,19 Discussion In addition to standard therapies, osteopathic manipulative treatment (OMT) may aid in the treatment of AD. The four guiding principles of OMT are: 9,10 1. The body is a unit; the person is a unit of mind, body and spirit. 2. The body is capable of self-regulation, selfhealing, and health maintenance. 3. Structure and function are reciprocally interrelated. 4. Rational treatment is based on an understanding of the basic principles of body unity, selfregulation, and the interrelationship of structure and function. Osteopathic physicians can use either direct or indirect techniques to restore the body s physiological function and treat somatic dysfunction. Somatic dysfunction is defined as the impaired or altered function of related components of the somatic system: skeletal, arthrodial, and myofascial structures and their related vascular, neural, and lymphatic elements. 5,9-11 Three OMT modalities useful in the treatment of atopic dermatitis -- myofascial release, lymphatic pump technique and soft tissue technique will be discussed as possible adjunct treatments and are described in Table 2. Myofascial release (MFR) works to disengage the restrictive barrier, placing all areas of fascial tension in a state of ease. This, in turn, decongests the lymphatic area. It can be performed anywhere from head to toe, since fascia surrounds and compartmentalizes all structures. 5 Myofascial release can be performed as a direct technique, by taking the fascia into a restrictive barrier, or it can be performed as an indirect technique, by taking the fascia into ease. To perform MFR, the physician must first find an area of myofascial strain, and then apply compression or distraction forces to the somatic dysfunction until the fascia releases and the strain is resolved. As previously mentioned, there are many palpable restrictive areas and tissue-texture abnormalities in patients with atopic dermatitis, and resolution of the strain is based on the physician s perceived response to palpation of the fascia. Physician applies compression or distraction forces to the somatic dysfunction; restricted fascia is encouraged into ease. Manipulation of soft tissue by palpation encourages increased circulation, lymphatic flow, and relaxation. Lymphatic pumping, soft tissue, and manual drainage promote fluid movement. Open surgical wounds, fractures, recent surgery, deep vein thrombosis, underlying neoplasms Open surgical wounds, fractures, underlying neoplasms Presence of metastatic cancer, tuberculosis or other infections, hypercoagulable states LEONE, ROWANE, LLOYD
3 Lymphatic techniques have been shown to enhance the lymphatic and immune systems through modulation of inflammatory mediators. Schander et al. found that lymphatic pump techniques significantly increase total leukocyte count, interleukin-8, and keratinocyte-derived chemoattractant following treatment. 12 Lymphatic pumps have been shown to have a positive effect on the B-lymphocyte and T-lymphocyte components of the immune system in peripheral blood. 13 According to Chikly, Sleszynski and Kelso conducted a one-year, randomized, researcher-blinded trial of the thoracic lymphatic pump in patients who had undergone low-risk cholecystectomy. 13 Patients treated with the thoracic lymphatic pump had earlier recovery and quicker return to preoperative values of forced vital capacity than those that did not receive treatment. There are four physiologic diaphragms in the human body that play a role in lymphatic return, including the tentorium cerebelli, thoracic inlet, abdominal diaphragm, and pelvic diaphragm. 5 The location of an AD flare determines which diaphragm to treat. Treatment of the thoracic inlet relaxes tissue restrictions and enhances lymphatic drainage from the head and neck. This is helpful in pediatric patients with atopic dermatitis on the face, commonly the malar cheeks. Releasing the tentorium cerebelli can treat lesions on the scalp, face, and neck, as well. Thoracoabdominaldiaphragm release increases lymphatic return from the rest of the body and may increase lymphatic flow to the chest and upper back. Treatment of the pelvic diaphragm increases lymphatic flow to the abdomen, buttocks, lower back, and pelvis. For lesions on the upper and lower extremities, release of the palmar fascia and plantar fascia, respectively, can be employed. Performance of these techniques by an osteopathic physician may enhance lymphatic flow to the affected skin while simultaneously decreasing immune congestion. (For visual instructions, see Figure 4.) Lymphatic techniques are relatively easy, non-invasive adjunct treatments that may improve outcomes in pediatric AD patients. Pediatric patients and parents or guardians must take an active role in management of AD. Topical emollients should be applied daily to protect and restore the epidermal layer. 1,2,6 OMT can be combined with the use of ointments or creams as an adjunct to treatment, either performed by the dermatologist, patient, or parent/guardian. The soft tissue techniques of effleurage, petrissage, friction, and tapotement can increase relaxation of surrounding fascia and promote lymphatic flow toward the lymphatic ducts (Figure 5). 5,9,10 Soft tissue techniques have been shown to increase tissue elasticity, enhance circulation to local fascial structures, improve local nutrition and oxygenation, and improve local immune response. 5 These osteopathic soft tissue techniques can be administered by the parent(s) or performed by the children themselves if they are old enough to participate in their own care. This is both cost effective and beneficial to the parents, in that it allows them to feel they are actively participating in the treatment process. We suggest parents or patients perform these techniques while applying medications, emollients and creams, which facilitates the standard of care and ensures that an adequate amount of time is spent applying medications so they are fully absorbed into the skin. Of course, if the parent(s) or patient is applying a steroid, it is important to wash hands or other areas that the steroid may have touched on the parent(s) or patient. Soft tissue techniques that can be utilized in atopic dermatitis include effleurage, skin rolling, stretching and petrissage. Effleurage is a light stroking soft-tissue technique that can be used on superficial eczematous plaques or patches. Skin rolling involves lifting the skin away from the deeper fascial structures and rolling it along the plane of treatment. 10 Petrissage is a deeper kneading and constant squeezing pressure. Although this treatment has been shown to improve pruritus, pain, and anxiety in patients with scars, it may be too invasive for pediatric AD patients and should be used at the physician s discretion. Instructions on how to perform these soft tissue techniques are provided below. A study comparing standard medical management alone to standard medical management with massage therapy found that patients receiving massage therapy had statistical improvement in redness, lichenification, scaling, excoriation and pruritus. 14 Although massage therapy differs from osteopathic soft tissue techniques in some ways, it can be inferred that using effleurage, petrissage, friction, and tapotement will benefit the patient with AD. Absolute contraindications to lymphatic technique include coagulopathy, chronic infections, and infections with risk of reactivation, such as tuberculosis. 16 Relative contraindications to lymphatic technique include active cancer, as there is a question as to whether lymphatic OMT can mobilize malignant cells. 16,17 Further studies are needed to determine the risk of initiating superinfections in eczematoid patients with open excoriations by performing OMT. Physicians should use best practices and wear gloves if they are touching any open, excoriated areas. There is clear evidence that patients with necrotizing fasciitis, abscess in the area, or systemic infection with temperature greater than 102 Fahrenheit (38.9 Celsius) should not be treated with OMT. 17 Time management is a major consideration in most dermatology practices. In a survey-based study conducted in 2003, dermatologists cited time restriction as a major barrier to performing OMT. 15 The techniques described here should not take more than five minutes to perform. A sample patient handout is included to help patients and/or parents perform osteopathic soft tissue techniques, with either emollient or medication, at home (Appendix 1). This may help to facilitate patient education, empower patients and parents, and decrease time spent on OMT in the office. Education for caregivers and patients is an important form of intervention. Since the pathogenesis of AD is complex and often requires multiple therapies, it also requires teaching and support to maintain a positive treatment response. 6 Examples of Osteopathic Manipulative Treatment Techniques Diaphragm Release 5,10 Choose the appropriate area to treat based on the location of visibly affected skin. Based on the respiratory-circulatory module, the thoracic inlet should be treated for lesions of the upper extremity, head, and neck (Figures 1a, 1b). For lesions of the lower extremity, treatment should begin with release of the pelvic diaphragm. Palpate the diaphragm, feeling for areas of somatic dysfunction, using compression, distraction, and the full respiratory cycle. Note areas of restriction and ease in diaphragmatic movement. While palpating the diaphragm, hold the tissue in the direction in which it moves most freely. Allow the fascia to unwind, at which point the tension should release, and rhythmic motion of the diaphragm should resume. Re-check the diaphragm to appreciate the motion gained, and a new end point should manifest. Lymphatic Technique Choose the appropriate area to treat based on the location of visibly affected skin. For example, if eczema flare is present in the cubital fossa, start distally (toward the wrist) and go proximally (toward the heart). Place the thumb on the extensor surface and the fingers on the flexor surface and apply pressure, moving the hand upward (Figure 2). Emollient can be applied at the distal site and massaged upward. Gloves should be worn. Steroid can be used on active flares. Take care not to put excessive pressure on active lesions, as this may irritate the skin. Soft-tissue Techniques Choose the appropriate area to treat based on the location of visibly affected skin. For example, if 1a. Thoracic-inlet release: Palpate the thoracic inlet, and motion test for restriction in rotation or side-bending. With the thoracic inlet in a state of either restriction (direct) or ease (indirect), palpate for a release point. 1b. Abdominal diaphragm release: Standing behind the patient, place hands underneath the ribcage as shown. Using respiration, palpate ease in the abdominal diaphragm until release.
4 Figure 2a Figure 2b 2a, 2b. For active eczema flares in the cubital fossa, hold the patient s wrist as shown. Apply gentle pressure, moving toward the armpit, to increase lymphatic flow to the heart. 3. Use gentle effleurage, moving toward the armpit, with or without topical medication or emollient. eczema flare is present in the cubital fossa, start distally (toward the wrist) and go proximally (toward the heart) (Figure 3). Move to a modified effleurage technique, using the palms to apply pressure directly up the arm, to the shoulder. If using an emollient, do not put excessive pressure directly on the lesion, as this may irritate the skin. Topical steroids or calcineurin inhibitors can be used on active flares. Use effleurage techniques to massage emollient gently in the distal-to-proximal direction. There is no specific end point to treatment. Once the emollient or medication is adequately absorbed, treatment can cease. Conclusion Atopic dermatitis affects not only the skin but also the whole patient, with emotional and psychological impacts. It represents a somatic dysfunction of the skin that can impact the structure and function of the body, creating upset in the body s homeostatic mechanisms. Because atopic dermatitis is an inflammatory process, osteopathic manipulative medicine can be used as an adjunctive therapy alongside traditional treatments recommended by the American Academy of Dermatology. Further studies are needed to address the effectiveness of OMT, the number of treatments needed to achieve maximum therapeutic benefit, and the response rates of pediatric patients. References 1. James WD, Berger TG, Elston DM. Andrew s diseases of the skin. Oxford: Elsevier; Chapter 5, Atopic Dermatitis; p Turner JD, Schwartz RA. Atopic dermatitis. A clinical challenge. Acta Dermatovenerol Alp Panonica Adriat Jun. 15(2): Eichenfield LF, Hanifin JF, Luger TA, Stevens SR, Pride HB. Consensus conference on pediatric atopic dermatitis. J Am Acad Dermatol Dec;49(6): Su JC, Kemp AS, Varigos GA, Nolan TM. Atopic eczema: its impact on the family and financial cost. Arch Dis Child Feb;76(2): Savarse R. OMT review; a comprehensive review of osteopathic medicine. 3rd ed. Legis Press; c2003. Chapter 12, Myofascial Release; p Eichenfield LF, Wynnis TL, Berger TG, et al. Guidelines of care for the management of atopic dermatitis. J Am Acad Dermatol Jul;71(1): Gerdes S, Kurrat W, Mrowietz U. Serum mast cell tryptase is not a useful marker for disease severity in psoriasis or atopic dermatitis. Br J Dermatol Apr;160(4): Buys LM. Treatment options for atopic dermatitis. Am Fam Physician Feb 15;75(4): Campbell SM, Winkelmann R, Walkowski S. Osteopathic manipulative treatment: novel application to dermatological disease. J Clin Aesthet Dermatol Oct;5(10): Belden S, Lloyd J, Rowane M. The scar as a representation of osteopathic principles. J Am Osteopath Coll Dermatol Oct 15;32: Chila A. Foundations of Osteopathic Medicine. 3 rd rev. ed. Philadelphia: Lippincott Williams & Wilkins; p Schander A, Downey HF, Hodge LM. Lymphatic pump manipulation mobilizes inflammatory mediators into lymphatic circulation. Exp Biol Med Jan;237(1): Chikly B. Manual techniques addressing the lymphatic system: origins and development. J Am Osteopath Assoc Oct;105: Schachner L. Atopic dermatitis symptoms decreased in children following massage therapy. Pediatr Dermatol Oct 15(5): Spaeth DG, Pheley AM. Evaluation of osteopathic manipulative treatments by Ohio osteopathic physicians in various specialties. J Am Osteopath Assoc Mar;102(3): Hibler J, Perkins J, Eland D, Sammons D. Osteopathic manipulative medicine for inflammatory skin diseases. J Am Osteopath Coll Dermatol. 2014;31: McIlwee BE, Lloyd JR, Rowane MP. Lymphatic complaints in the dermatology clinic: an osteopathic approach. J Am Osteopath Coll Dermatol. 2016;35: Eichenfield LF, Friedlander SF, Simpson EL, Irvine AD. Assessing the new and emerging treatments for atopic dermatitis. Semin Cutan Med Surg Jun;35(5 Suppl):S Paller AS, Tom WL, Lebwohl MG, et al. Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults. J Am Acad Dermatol Sep;75(3): LEONE, ROWANE, LLOYD
5 Appendix 1. Performing Soft Tissue Techniques for Atopic Dermatitis at Home For upper-extremity eczema flare (often located in the elbow crease) For a parent, guardian, or other supervisor: 1. Wearing latex-free gloves, apply a quarter-sized drop of emollient on the patient s extremity, at the location farthest from the heart. (For example, to treat an eczema flare on the inner elbow crease, the emollient is applied on the back of the wrist.) 3. Using squeezing pressure, advance up the arm to the armpit, being careful to use minimal pressure over the active eczema flare in the elbow surface. This step can be repeated three to four times. 2. Place your thumb on the forearm and your fingers on the back of the forearm (on the side closest to the eczema flare). 4. Place your fingers on the back of the wrist and your thumb on the forearm, and massage up to the armpit using a sustained, gentle pressure, again being careful not to put too much pressure on the active eczema flare. 5. Starting at the wrist, use your fingers to gently massage up to the armpit, keeping them in constant contact with the skin.
What is atopic dermatitis?
What is atopic dermatitis? Complex inflammatory skin disorder intense pruritus cutaneous hyperreactivity immune dysregulation Chronic with exacerbations and remissions Affects all ages, but more common
More informationUPDATES IN ATOPIC DERMATITIS
UPDATES IN ATOPIC DERMATITIS Amanda Hess, MMS, PA-C President-Elect, AAPA-AAI Arizona Asthma and Allergy Institute, Scottsdale, AZ LEARNING OBJECTIVES Discuss epidemiology, risk factors, and causes of
More informationAssessing the Current Treatment of Atopic Dermatitis: Unmet Needs
Transcript Details This is a transcript of a continuing medical education (CME) activity accessible on the ReachMD network. Additional media formats for the activity and full activity details (including
More informationThe Itch That Rashes. Sarah D. Cipriano, MD, MPH, MS Resident, Dermatology University of Utah
The Itch That Rashes Sarah D. Cipriano, MD, MPH, MS Resident, Dermatology University of Utah 1 Conflict of Interest No conflict of interest Will discuss off label use of medications 2 3 Most likely diagnosis?
More informationItchy babies: Current treatment guidelines for atopic dermatitis
Itchy babies: Current treatment guidelines for atopic dermatitis Rachel Laarman, MD Helen DeVos Children s Hospital Grand Rapids, MI Photo cred: www.dermatologytimes.modernmedicine.com I have no disclosures
More informationBiologic Therapies for Atopic Dermatitis and Beyond
Biologic Therapies for Atopic Dermatitis and Beyond Jonathan Corren, M.D. Departments of Medicine and Pediatrics, David Geffen School of Medicine at UCLA Disclosures Genentech - research Medimmune/AZ -
More informationDermatitis (inflammatory skin condition) Nonallergic. dermatitis. Non-atopic eczema (non- IgE mediated)
Atopic Eczema Dermatitis (inflammatory skin condition) Allergic dermatitis -eczema Nonallergic dermatitis Atopic eczema (IgE mediated) Non-atopic eczema (non- IgE mediated) Pathophysiology of Eczema Allergy
More informationMedication Policy Manual. Topic: Dupixent, dupilumab Date of Origin: March 10, Committee Approval: March 10, 2017 Next Review Date: May 2018
Independent licensees of the Blue Cross and Blue Shield Association Medication Policy Manual Policy No: dru493 Topic: Dupixent, dupilumab Date of Origin: March 10, 2017 Committee Approval: March 10, 2017
More informationEczema. By:- Dr. Naif Al-Shahrani Salman bin Abdazziz University
Eczema By:- Dr. Naif Al-Shahrani Salman bin Abdazziz University Dermatitis= Eczema =Spongiosis Eczema Atopic Seborrheic Contact Allergic Irritant Nummular Asteatotic Stasis Neurodermatitis/Lichen Simplex
More informationTopical Immunomodulator Step Therapy Program
Topical Immunomodulator Step Therapy Program Policy Number: 5.01.557 Last Review: 8/2017 Origination: 7/2013 Next Review: 8/2018 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) BCBSKC will provide
More informationATOPIC DERMATITIS: A BLUEPRINT FOR SUCCESS. Sierra Wolter MD, FAAD Pediatric Dermatology University of Arizona, College of Medicine
ATOPIC DERMATITIS: A BLUEPRINT FOR SUCCESS Sierra Wolter MD, FAAD Pediatric Dermatology University of Arizona, College of Medicine THE PLAN Is it atopic dermatitis? What is atopic dermatitis? Guidelines
More informationLearning Circle: Jan 26, 2011 Childhood Eczema
Learning Circle: Jan 26, 2011 Childhood Eczema Wingfield Rehmus, MD MPH BC Children s Hospital Clinical Assistant Professor, UBC Department of Paediatrics Associate Member, UBC Department of Dermatology
More informationAn Everyday Guide to Eczema
An Everyday Guide to Eczema By Dr. Kristel Polder, Board-Certified Dermatologist Developed in Partnership with Who is affected by eczema? 32 million people in the US 1 in 5 children 1 in 12 adults *www.eczema.org
More informationAtopic Eczema with detail on how to apply wet wraps
Atopic Eczema with detail on how to apply wet wraps Dr Carol Hlela Consultant Dermatologist Head of Unit, Department of Dermatology, Paediatrics Red Cross Children s Hospital, UCT Red Cross War Memorial
More informationTopical Doxepin Prior Authorization with Quantity Limit Program Summary
Topical Doxepin Prior Authorization with Quantity Limit Program Summary FDA APPROVED INDICATIONS DOSAGE 1-3 Agent(s) Indication(s) Dosage & Administration Doxepin 5% cream Prudoxin (doxepin) cream 5% KS_PS_Topical_Doxepin_PAQL_ProgSum_AR1018
More informationRobert P Schneider DO FAAFP MYOFASCIAL RELEASE
Robert P Schneider DO FAAFP MYOFASCIAL RELEASE Objectives Review basic anatomy. Describe diagnosis of somatic dysfunction using a fascial model. Summarize the basic concepts of myofascial release (MFR)
More informationJAOCD. Journal Of The American Osteopathic College Of Dermatology. Primary Cutaneous Blastomycosis Masquerading as Pyoderma
Volume 39 January 2018 JAOCD Journal Of The American Osteopathic College Of Dermatology Primary Cutaneous Blastomycosis Masquerading as Pyoderma Also in this issue: OMT as Adjunct Treatment for Pediatric
More information過敏病科中心. Allergy Centre. Eczema. Allergy Centre 過敏病科中心. Allergy Centre. For enquiries and appointments, please contact us at:
Allergy Centre 過敏病科中心 Eczema For enquiries and appointments, please contact us at: Allergy Centre 9/F, Li Shu Pui Block Hong Kong Sanatorium & Hospital 2 Village Road, Happy Valley, Hong Kong Tel: 2835
More informationMy Algorithm. Questions to ask. Do you or your family have a history of?... Allergic rhinitis, Sensitive skin, Asthma Skin Cancer
Tracey C. Vlahovic, DPM Associate Professor, Temple University School of Podiatric Medicine My Algorithm Inflammatory Skin Disorder on Feet Family hx, clinical exam, look at hands! Defined plaques: Psoriasis
More informationWhat s Topical About Topicals?
What s Topical About Topicals? Megha M. Tollefson, MD Associate Professor of Dermatology and Pediatrics July 29, 2017 2015 MFMER 3513105-1 Disclosures None 2015 MFMER 3513105-2 Outline Topical steroids
More informationChildren s Hospital Of Wisconsin
Children s Hospital Of Wisconsin Co-Management Guidelines To support collaborative care, we have developed guidelines for our community providers to utilize when referring to, and managing patients with,
More informationUpdate on emollients
Update on emollients Amal Mhanna, MD Pediatric Dermatologist Clemenceau Medical Center Disclosure: I was a member of an advisory board y for J&J and received honoraria. Emollients and moisturizers are
More informationCHAPTER 1. Eczema Basics
CHAPTER 1 Eczema Basics Definition Eczema is an inflammatory skin condition, characterised by ichtyosis (dry skin), erythema (redness), excoriation (interruption of the skin), scratching lesions, lichenification
More informationDiagnosis and Management of Common and Infective Skin Diseases in Children at primary care level
Diagnosis and Management of Common and Infective Skin Diseases in Children at primary care level Dr Ng Su Yuen Paediatrician and Paediatric Dermatologist Hospital Pulau Pinang Outline Common inflammatory
More informationEczema & Dermatitis Clinical features: Histopathological features: Classification:
Eczema & Dermatitis Eczema is an inflammatory reactive pattern of skin to many and different stimuli characterized by itching, redness, scaling and clustered papulovesicles. Eczema and dermatitis are synonymous
More informationSCS FAMILY MEDICINE Introduction in Osteopathic Principles & Initial Osteopathic Evaluation for Low Back Pain
SCS FAMILY MEDICINE Introduction in Osteopathic Principles & Initial Osteopathic Evaluation for Low Back Pain CATHERINE DONAHUE D.O. ASSISTANT PROFESSOR DEPARTMENT OF OMM MSUCOM WHAT WE WILL COVER Osteopathic
More informationFREE CPE OPPORTUNITY
FREE CPE OPPORTUNITY Knowledge of Classical Massage Movements CHALLENGE Complete all Questions In the workbook exam paper attached Send in your Answers office@maa.org.au Collect 20 CPE Points for 90% -
More informationNovel Insights in Atopic Dermatitis: Pathways, Biomarkers, and Phenotypes for a Targeted Approach Transcript
Novel Insights in Atopic Dermatitis: Pathways, Biomarkers, and Phenotypes for a Targeted Approach Transcript Title Slide Welcome to the CME-certified program: Novel Insights in Atopic Dermatitis; Pathways,
More informationAllergic versus Contact
Allergic versus Contact Dermatitis Julie Sterbank, DO Assistant Clinical Professor Allergy/Immunology MetroHealth Medical Center/Case Western Reserve University Disclosure I have no financial disclosures
More informationAn Update on Topical Therapy for Atopic Dermatitis
An Update on Topical Therapy for Atopic Dermatitis Amy S. Paller, M.D. Professor and Chair of Dermatology Professor of Pediatrics Northwestern University Feinberg School of Medicine Chicago, Illinois Disclosures
More informationEichenfield: Neonatal Dermatology
What You Need to Know about Pediatric Dermatology Lawrence F. Eichenfield, M.D. Professor of Dermatology and Pediatrics University of California, San Diego Rady Children s Hospital, San Diego Disclosures
More informationRunning head: ATOPIC DERMATITIS, ITS IMPACT AND TREATMENT
Atopic Dermatitis, Its Impact and Treatment Running head: ATOPIC DERMATITIS, ITS IMPACT AND TREATMENT The Impact of Treatment on Quality of Life of Children with Atopic Dermatitis and their Families Consuela
More informationMUSCLE ENERGY FOR CERVICAL SPINE. Dr. Gabrielle Koczab, DO Medical director Bedford Primary Care Core Teaching Faculty UH Regional Hospitals
MUSCLE ENERGY FOR CERVICAL SPINE Dr. Gabrielle Koczab, DO Medical director Bedford Primary Care Core Teaching Faculty UH Regional Hospitals LEARNING OBJECTIVES 1. List conditions in which muscle energy
More informationThe skin is the largest organ of the human body. Functions: protection sensation maintain temperature vitamin synthesis
Dermatology The skin is the largest organ of the human body. Functions: protection sensation maintain temperature vitamin synthesis The image to the left shows an image of skin cells and the proteins which
More informationATOPIC ECZEMA. What are the aims of this leaflet?
ATOPIC ECZEMA What are the aims of this leaflet? This leaflet has been written to help you understand more about atopic eczema. It tells you what it is, what causes it, what can be done about it, and where
More informationEczema. Most kids get itchy rashes at one time or another. But eczema can be a nuisance that may prompt scratching that makes the problem worse.
KidsHealth.org The most-visited site devoted to children's health and development Eczema Most kids get itchy rashes at one time or another. But eczema can be a nuisance that may prompt scratching that
More informationAtopic Dermatitis Topics discussed
Dr.F.Shariati Atopic Dermatitis Topics discussed Diagnosis of eczema Incidence Aggravators History and assessment Treatments Clinical Cases Contact details and clinics Eczema = TERMINOLOGY Greek term To
More informationThe Role of Allergen Immunotherapy and Biologicals in the Treatment of Atopic Dermatitis
The Role of Allergen Immunotherapy and Biologicals in the Treatment of Atopic Dermatitis John Oppenheimer MD Div Allergy and Immunology UMDNJ-Rutgers Potential Conflicts of Interest Consultant GSK, Teva,
More informationNovan Announces Promising Clinical Results with SB414
Novan Announces Promising Clinical Results with SB414 In the recently completed Phase 1b trial for atopic dermatitis, clinical efficacy measures were highly correlated with critical and disease-relevant
More informationUnderstanding. Atopic Dermatitis. National Jewish Health. An educational health series from
Understanding Atopic Dermatitis An educational health series from National Jewish Health If you would like further information about National Jewish Health, please write to: National Jewish Health 1400
More information1. Erythema. 2. Edema/papulation. 3. Excoriation 4. Lichenification
How to Use EASI The EASI scoring system uses a defined process to grade the severity of the signs of eczema and the extent affected: 1. Select a body region Four body regions are considered separately:
More informationSkin Deep: Or is It? Practical Pearls from a Pediatric Dermatologist
Skin Deep: Or is It? Practical Pearls from a Pediatric Dermatologist I have no conflicts of interest 6 yo boy referred for AD. On topical HC and food elimination diet s/p topical triamcinolone to body
More informationClinico Pathological Test SCPA605-Essential Pathology
Clinico Pathological Test SCPA605-Essential Pathology Somphong Narkpinit, M.D. Department of Pathogbiology, Faculty of Science, Mahidol University e-mail : somphong.nar@mahidol.ac.th Pathogenesis of allergic
More informationConstitutional eczema
Patient information Constitutional eczema What is constitutional eczema? Constitutional eczema, also called atopic eczema, is a form of eczema that mainly occurs in childhood. Eczema usually starts before
More informationPNW EPC Drug Effectiveness Review Project Summary Report Atopic Dermatitis New Drug Evaluation: Dupilumab
Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119
More informationATOPIC DERMATITIS: PATHOPHYSIOLOGY AND PHARMACOLOGY OF MANAGEMENT PEGGY VERNON, RN, MA, C-PNP, DCNP, FAANP
ATOPIC DERMATITIS: PATHOPHYSIOLOGY AND PHARMACOLOGY OF MANAGEMENT PEGGY VERNON, RN, MA, C-PNP, DCNP, FAANP Disclosures Promotional Speaker for Pfizer, Inc. Any unlabeled/unapproved uses of drugs or products
More informationManaging and Minimizing Flare-ups in Atopic Dermatitis
Managing and Minimizing Flare-ups in Atopic Dermatitis Importance of the skin barrier & how commonly used drugs are impacting it Dr. Benjamin Barankin, MD FRCPC Medical Director & Founder of Toronto Dermatology
More informationCOMMON SKIN CONDITIONS IN PRIMARY CARE. Ibrahim M. Zayneh, MD Dermatology Private Practice, Portsmouth, Ohio
COMMON SKIN CONDITIONS IN PRIMARY CARE Ibrahim M. Zayneh, MD Dermatology Private Practice, Portsmouth, Ohio DISCLOSURE The Speaker and members of the planning committee do not have a conflict of interest
More informationWhat caused this refractory pruritic eruption? Patient Presentation
What caused this refractory pruritic eruption? Patient Presentation A 67 year-old female presented with greater than 3 years of refractory and debilitating intermittent bouts of recurrent pruritus on the
More informationProspective Trial Comparing Topical Steroid Application To Wet Versus Dry Skin In Children With Atopic Dermatitis
Yale University EliScholar A Digital Platform for Scholarly Publishing at Yale Yale Medicine Thesis Digital Library School of Medicine January 2014 Prospective Trial Comparing Topical Steroid Application
More informationRELEVANT DISCLOSURES ATOPIC DERMATITIS / ECZEMA MANAGING ECZEMA IN INFANTS AND CHILDREN
RELEVANT DISCLOSURES MANAGING ECZEMA IN INFANTS AND CHILDREN Advisory board member - MEDA (Elidel), Speaking honoraria Bayer (Advantan) Advisory board, consultant, speaker: Pfizer, Abbvie, Janssen, Elli
More informationAllergic Disorders. Allergic Disorders. IgE-dependent Release of Inflammatory Mediators. TH1/TH2 Paradigm
Allergic Disorders Anne-Marie Irani, MD Virginia Commonwealth University Allergic Disorders IgE-mediated immune reactions Clinical entities include: asthma allergic rhinitis atopic dermatitis urticaria
More informationAllergic Disorders. Allergic Disorders. IgE-dependent Release of Inflammatory Mediators. TH1/TH2 Paradigm
Allergic Disorders Anne-Marie Irani, MD Virginia Commonwealth University Allergic Disorders IgE-mediated immune reactions Clinical entities include: asthma allergic rhinitis atopic dermatitis urticaria
More informationDermatology elective for yr. 5. Natta Rajatanavin, MD. Div. of dermatology Dep. Of Medicine, Ramathibodi Hospital Mahidol University 23 rd Feb 2015
Dermatology elective for yr. 5 Natta Rajatanavin, MD. Div. of dermatology Dep. Of Medicine, Ramathibodi Hospital Mahidol University 23 rd Feb 2015 How to diagnosis and manage eczema and psoriasis. Objectives
More informationSkin lesions & Abrasions
Skin lesions & Abrasions What Are Skin Lesions? A skin lesion is a part of the skin that has an abnormal growth or appearance compared to the skin around it Types of Skin Lesions Two types of skin lesions
More informationHandout on Health: Atopic Dermatitis (A type of eczema)
Handout on Health: Atopic Dermatitis (A type of eczema) This publication is for people who have atopic dermatitis (often called eczema ), parents and caregivers of children with atopic dermatitis, and
More informationOMT Boot Camp. OMT Test Format and Test Taking Skills (Written and Practical) Thomas E. Sabalake, DO
ACOFP 54 th Annual Convention & Scientific Seminars OMT Boot Camp OMT Test Format and Test Taking Skills (Written and Practical) Thomas E. Sabalake, DO ACOFP OMT BOOT CAMP 2017 OMT TEST FORMAT AND TEST
More informationManagement of eczema in infants and children Assoc Prof David Orchard Director, Department of Dermatology Royal Children s Hospital
Atopic dermatitis definition Management of eczema in infants and children Assoc Prof David Orchard Director, Department of Dermatology Royal Children s Hospital Atopic dermatitis is long lasting (chronic)
More informationA*STAR skin examination protocol
A*STAR skin examination protocol Professor Carsten Flohr Chair in Dermatology and Population Science & Consultant Dermatologist Unit for Population-Based Dermatology Research St John s Institute of Dermatology
More informationTechnology appraisal guidance Published: 25 August 2004 nice.org.uk/guidance/ta82
Tacrolimus and pimecrolimus for atopic eczema Technology appraisal guidance Published: 25 August 2004 nice.org.uk/guidance/ta82 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).
More informationMarch 9, 2015 From: The Pediatric Dermatology Research Alliance (PeDRA)
Web: www.pedraresearch.org From: The Pediatric Dermatology Research Alliance (PeDRA) To: Jennifer Shepherd, Center for Drug Evaluation and Research Food and Drug Administration, 10903 New Hampshire Ave.,
More informationComparative efficacy of topical mometasone furoate 0.1% cream vs topical tacrolimus 0.03% ointment in the treatment of atopic dermatitis
Original Article Comparative efficacy of topical mometasone furoate 0.1% cream vs topical tacrolimus 0.03% ointment in the treatment of atopic dermatitis Md Alauddin Khan *, Lubna Khondker **, Dilshad
More informationWhat is Psoriasis? Common Areas Affected. Type Who Does it Affect Characteristics
What is? is a term derived from the Greek word psōra which means itch and is a common, long lasting, inflammatory skin condition which affects 1-3% of the UK population and about 80 million people worldwide.
More informationThe EASI scoring system uses a defined process to grade the severity of the signs of eczema and the extent affected:
How to Use EASI The EASI scoring system uses a defined process to grade the severity of the signs of eczema and the extent affected: 1. Select a body region Four body regions are considered separately:
More informationDupilumab and Crisaborole for Atopic Dermatitis: Effectiveness, Value, and Value-Based Price Benchmarks
Dupilumab and Crisaborole for Atopic Dermatitis: Effectiveness, Value, and Value-Based Price Benchmarks Draft Background and Scope November 7, 2016 Background: Atopic dermatitis (eczema) is a chronic/chronically-relapsing
More informationDocumentation and Billing For Myofacial Disruption Treatment
Documentation and Billing For Myofacial Disruption Treatment Page 1 of 7 Documentation Requirements The following information comes directly from the American Medical Association CPT coding Committee:
More informationVulval dermatoses. Dr Fiona Lewis, Consultant Dermatologist St John s Institute of Dermatology, London & Heatherwood & Wexham Park Hospital, Slough
Vulval dermatoses Dr Fiona Lewis, Consultant Dermatologist St John s Institute of Dermatology, London & Heatherwood & Wexham Park Hospital, Slough Pigmentation Vulvodynia Ulcers Genetic Pruritus VULVAL
More informationWhat is Lymphedema? Primary lymphedema: a person is born with the condition where the lymphatic vessels are not formed completely or malformed
Lymphedema What is Lymphedema? Lymphedema is a chronic health condition which causes localized swelling. There are 2 types: Primary lymphedema: a person is born with the condition where the lymphatic vessels
More informationAtopic Dermatitis Guidelines: What s New?
Atopic Dermatitis Guidelines: What s New? Lawrence F. Eichenfield, M.D. Professor of Dermatology and Pediatrics University of California, San Diego Rady Children s Hospital, San Diego Anacor/Pfizer Genentech
More information34b Chair Massage! Technique Review and Practice!
34b Chair Massage! Technique Review and Practice! 34b Chair Massage: Technique Review and Practice! Class Outline" 5 minutes "Attendance, Breath of Arrival, and Reminders " 10 minutes "Lecture:" 25 minutes
More informationDrug allergy and Skin Disorders. Timothy Craig, DO, FACOI Professor of Medicine and Pediatrics Distinguished Educator Penn State University, Hershey
Drug allergy and Skin Disorders Timothy Craig, DO, FACOI Professor of Medicine and Pediatrics Distinguished Educator Penn State University, Hershey The best screening test for anaphylaxis is? A. histamine
More informationLessons Learned from the International Eczema Council (IEC)
Lessons Learned from the International Eczema Council (IEC) Amy S. Paller, MD Northwestern University Feinberg School of Medicine American Academy of Dermatology meeting F046 February 17, 2017 No conflicts
More informationeczema the basics 2EE6E629CEA25112ABD0B8EB Eczema The Basics 1 / 6
Eczema The Basics 1 / 6 2 / 6 3 / 6 Eczema The Basics Eczema is a group of conditions that cause inflammation of the skin. Typically, eczema causes skin to become itchy, red, and dry -- even cracked and
More informationRecalcitrant Warty Erythroderma With Severe Pruritus. Gil Yosipovitch Professor & Chair Department of Dermatology & Itch Center Temple University
Recalcitrant Warty Erythroderma With Severe Pruritus Gil Yosipovitch Professor & Chair Department of Dermatology & Itch Center Temple University DISCLOSURE OF RELEVANT RELATIONSHIPS WITH INDUSTRY Gil Yosipovitch,
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Flutarzole 0,05% w/w cream, Fluticasone propionate
PACKAGE LEAFLET: INFORMATION FOR THE USER Flutarzole 0,05% w/w cream, Fluticasone propionate 1. IDENTIFICATION OF THE MEDICINAL PRODUCT 1.1. Trade name Flutarzole 1.2. Composition Active substance: Fluticasone
More information15 minute eczema consultation
THERAPY WORKSHOP 15 minute eczema consultation History Current treatments Examination Treatment Plan Written action plan Soap substitute/bath oil Antiseptic baths Emollients Topical steroids Other treatments
More informationManual Manipulative Medicine: A Structural Examination for Lower Back Pain. Friday, October 2, :30 AM - 12:00 PM W116.
Manual Manipulative Medicine: A Structural Examination for Lower Back Pain Friday, October 2, 2015 10:30 AM - 12:00 PM W116. Level: Beginner No Financial Disclosures Amir Mahajer, DO Ronald Tolchin, DO
More informationContact Dermatitis Challenges for the General Dermatologist. Susan Nedorost, MD
Contact Dermatitis Challenges for the General Dermatologist Susan Nedorost, MD Contact Dermatitis: Challenges for the General Dermatologist Disclosure Statement I, Susan Nedorost, MD, do not have any relevant
More information34b Chair Massage! Technique Review and Practice!
34b Chair Massage! Technique Review and Practice! 34b Chair Massage: Technique Review and Practice! Class Outline" 5 minutes "Attendance, Breath of Arrival, and Reminders " 10 minutes "Lecture:" 25 minutes
More informationOMM: PAIN MANAGEMENT FOR REDUCING THE NEED FOR MEDICATIONS JORDAN KEYS D.O. M.S. OBJECTIVES. By the end of this session the attendees will be able to:
OMM: PAIN MANAGEMENT FOR REDUCING THE NEED FOR MEDICATIONS JORDAN KEYS D.O. M.S. OBJECTIVES By the end of this session the attendees will be able to: Understand the basics of pain and pain perception.
More informationNovan Provides Update on SB414 Inflammatory Skin Disease Development Program
Novan Provides Update on SB414 Inflammatory Skin Disease Development Program SB414 Nitric Oxide-Releasing Cream Safe and Well-Tolerated in Psoriasis Phase 1b Trial Preclinical Data with SB414 Targeting
More informationSOLARIS. Exo. Off-the-Shelf Gradient Compression Garments
SOLARIS F R E E D O M T O L I V E Exo B Y S O L A R I S Off-the-Shelf Gradient Compression Garments Table of Contents 3 4 6 8 4 6 3 Contact Information Why Choose Exo Exo Quick Reference Chart Upper Extremity
More informationOsteopathic Manipulation Background and Indications
Osteopathic Manipulation Background and Indications Kelley Harmon, D.O. Maine Dartmouth Family Medicine Residency MaineGeneral Medical Center Augusta, Maine Regional Assist. Dean, University of New England
More informationATOPIC DERMATITIS: PATHOPHYSIOLOGY AND PHARMACOLOGY OF MANAGEMENT PEGGY VERNON, RN, MA, C-PNP, DCNP, FAANP
ATOPIC DERMATITIS: PATHOPHYSIOLOGY AND PHARMACOLOGY OF MANAGEMENT PEGGY VERNON, RN, MA, C-PNP, DCNP, FAANP Disclosures There are no financial relationships with commercial interests to disclose Ay unlabeled/unapproved
More informationUSAG BAVARIA SPORTS & FITNESS. MassageProgram
USAG BAVARIA SPORTS & FITNESS MassageProgram STRESS A remedy proven through the ages, with clinical results for blood pressure, muscle tone and chronic pain. DESK JOB Are you suffering from sitting at
More informationManual Therapy Techniques
Manual Therapy Techniques manual therapy: the use of hands-on techniques to evaluate, treat, and improve the status of neuromusculoskeletal conditions massage: the systematic and scientific manipulation
More informationPNW EPC Drug Effectiveness Review Project Summary Report Atopic Dermatitis New Drug Evaluation: Dupilumab
Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119
More informationThe Use of Seated Facet Release in Children
The Use of Seated Facet Release in Children Karen M. Steele, DO, FAAO Professor Emerita, West Virginia School of Osteopathic Medicine Former AAO President Outline of lab Pedigree Basic Principles Diagnosis
More information1 / 5. الابط في الحبيبي التقرن نظير=- parakeratosis Axillary granular
1 / 5 الابط في الحبيبي التقرن نظير=- parakeratosis Axillary granular Axillary Granular manifesting cutaneous parakeratosis antiperspirants agents. sweating, granular Granular parakeratosis, and, folds.
More informationAtopic Dermatitis: Therapeutic Challenges
Atopic Dermatitis: Therapeutic Challenges PDA August 14, 2009 Jon Hanifin OHSU, Portland Dominant Concepts in Atopic Dermatitis Allergy / Immunology Era: 1915-2006 The Epidermal Era: 2006---- Barrier dysfunction
More information2/25/17. Translating the Evidence: Allergy vs. Dermatology. How can they disagree?! Bias: It doesn t come out in the wash. wash. Precision Medicine
Translating the Evidence: Allergy vs. Dermatology Peter A. Lio, MD, FAAD Assistant Professor Clinical Dermatology & Pediatrics Northwestern University Feinberg School of Medicine How can they disagree?!
More informationProfessor Rohan Ameratunga Clinical Immunologist and Allergist Auckland
Professor Rohan Ameratunga Clinical Immunologist and Allergist Auckland 16:30-17:25 WS #170: Eczema Management 17:35-18:30 WS #182: Eczema Management (Repeated) Managing ECZEMA A/Prof Rohan Ameratunga
More informationNew Medicine Report. Pimecrolimus. RED- Hospital only Date of Last Revision 6 th March 2003
New Medicine Report Document Status Pimecrolimus Reviewed by Suffolk D&T RED- Hospital only Date of Last Revision 6 th March 2003 Approved Name Pimecrolimus Trade Name Elidel Manufacturer Novartis Legal
More informationTRIGGERS & TREATMENT OF ATOPIC DERMATITIS COA#PCIA0809 CE Activity provided by PCI Journal
TRIGGERS & TREATMENT OF ATOPIC DERMATITIS COA#PCIA0809 CE Activity provided by PCI Journal INSTRUCTIONS 1. Read the article. 2. Take the test, record your answers in the test answer section (Section B)
More informationIf looking for a book Psoriasis Cure: Treatments, Natural Remedies and Best Home Managements (Skin Disease, Skin Problems, Skin Diseases and
Psoriasis Cure: Treatments, Natural Remedies And Best Home Managements (Skin Disease, Skin Problems, Skin Diseases And Disorders Book 1) By Jeff Kennedy READ ONLINE If looking for a book Psoriasis Cure:
More informationPrescribing Information
Prescribing Information Pr DERMOVATE Cream (clobetasol propionate cream, USP) Pr DERMOVATE Ointment (clobetasol propionate ointment, USP) Topical corticosteroid TaroPharma Preparation Date: A Division
More informationProceedings of the 36th World Small Animal Veterinary Congress WSAVA
www.ivis.org Proceedings of the 36th World Small Animal Veterinary Congress WSAVA Oct. 14-17, 2011 Jeju, Korea Next Congress: Reprinted in IVIS with the permission of WSAVA http://www.ivis.org 14(Fri)
More informationExercises and advice following your breast reconstruction surgery
Exercises and advice following your breast reconstruction surgery This leaflet gives information to people who have had breast reconstructive surgery. It contains exercises that your physiotherapist would
More informationExercises and advice following your breast surgery and axillary node clearance (ANC)
Exercises and advice following your breast surgery and axillary node clearance (ANC) This leaflet gives information to people who have had breast surgery. It contains exercises that your physiotherapist
More information79b Orthopedic Massage: Technique Demo and Practice! Rotator Cuff and Carpal Tunnel!
79b Orthopedic Massage: Technique Demo and Practice! Rotator Cuff and Carpal Tunnel! 79b Orthopedic Massage: Technique Demo and Practice! Rotator Cuff and Carpal Tunnel! Class Outline" 5 minutes" "Attendance,
More information